PLOS ONE | https://doi.org/10.1371/journal.pone.0186835 October 30, 2017
The European Journal of Public Health, Vol. 28, No. 1, 145–149
The Author 2017. Published by Oxford University Press on behalf of the European Public Health Association.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:...//creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
doi:10.1093/eurpub/ckx122 Advance Access published on 31 August 2017
more
J Epidemiol Community Health 2011;65:1166e1170. doi:10.1136/jech.2009.097469
В помощь руководи*телям и практикующим врачам приведены конкретные меры, направ*ленные на улучшение медицинской помощи и обеспечение равногодоступа к не...й заключенных, необходимые юридические инструменты, рекомендации по организации работы лабораторных и противотубер*кулезных служб, методы диагностики и ведения больных, образцыспециальной документации, перечни профилактических и санитарно*просветительных мероприятий.
more
PLOS ONE | https://doi.org/10.1371/journal.pone.0203986 October 3, 2018
Original Article
SAGE Open Medicine Volume 5: 1–7 © The Author(s) 2017 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav httpDs:O//dIo: i1.o0r.g1/107.171/2770/52035013212171773311977 journals.sagepub.com/home/smo
Evaluation report
September 2014
Country Progress Report
Reporting Period
January – December, 2014
Accessed: 26.09.2019
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0169530 February 16, 2017
Rueda S, et al. BMJ Open 2016;6:e011453. doi:10.1136/bmjopen-2016-011453
PeerJ PrePrints , http://dx.doi.org/10.7287/peerj.preprints.579v1 2 Nov 2014
2006-2008 programme report
World Drug Report 2018
-2-
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o...f their country of practice. Some medications may not be available in some countries and readers should consult the specific drug information since not all the unwanted effects of medications are mentioned.
more
National Tuberculosis Programme
The National Strategic Plan (NSP) for Tuberculosis (TB) 2016-2020 builds on the past experiences for the National Tuberculosis Programme and its partners. This NSP provides a roadmap for delivering quality TB prevention and care service to the entire population, ...as an integral part of the country's move toward Universal Health Coverage. Between 1990 and 2015, Myanmar reduced the prevalence of TB by 50%, meeting the targets set by the Millennium Development Goals. Going forward, the country aims to further accelerate the rate decline.
more
Infectious Diseases of Poverty 2014, 3:42
http://www.idpjournal.com/content/3/1/42
J. European Academy of Dermatology and Venereology, 4 August 2014